Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
02/18/2022 | Mosaic ImmunoEngineering Inc. | PTSC | Other (acquisition) | | 0 | $20,000.00 | $0 | | 02/18/2022 |
09/03/2021 | Oncotelic Therapeutics, Inc. | MATN | Grant | Stock Options | 500k | $0.14 | $69.6k | | 09/03/2021 |
07/08/2021 | Oncotelic Therapeutics, Inc. | MATN | Grant | Stock Options | 357.4k | $0.16 | $58.1k | | 03/31/2021 |
03/31/2021 | Oncotelic Therapeutics, Inc. | MATN | Conversion | Common Stock | 3.3M | $0.00 | $0 | By Artius Bioconsulting | 03/31/2021 |
03/31/2021 | Oncotelic Therapeutics, Inc. | MATN | Conversion | Series A Convertible Preferred Stock | 3.3k | $0.00 | $0 | By Artius Bioconsulting | 03/31/2021 |
01/29/2021 | Mosaic ImmunoEngineering Inc. | PTSC | Conversion | Common Stock | 1.6M | $0.00 | $0 | | 01/29/2021 |
01/29/2021 | Mosaic ImmunoEngineering Inc. | PTSC | Conversion | Series A Convertible Voting Preferred Stock | 161k | $0.00 | $0 | | 01/29/2021 |
12/16/2020 | Mosaic ImmunoEngineering Inc. | PTSC | Grant | Restricted Stock Units | 43.5k | $3.30 | $143.5k | | 12/16/2020 |
12/16/2020 | Mosaic ImmunoEngineering Inc. | PTSC | Grant | Restricted Stock Units | 65.2k | $3.30 | $215.2k | | 12/16/2020 |
10/31/2017 | Avid Bioservices, Inc. | CDMO | Other (acquisition) | Common Stock | 1.4k | $3.87 | $5.4k | | 10/31/2017 |
06/02/2016 | Avid Bioservices, Inc. | CDMO | Grant | Stock Option (right to buy) | 500k | $0.50 | $250k | | 06/02/2016 |
10/31/2011 | Avid Bioservices, Inc. | CDMO | Other (acquisition) | Common Stock | 4.8k | $0.89 | $4.3k | | 10/31/2011 |
09/23/2010 | Avid Bioservices, Inc. | CDMO | Purchase | Common Stock, $0.001 par value | 5k | $1.33 | $6.6k | | 09/23/2010 |